Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Hemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
PubMed Similar studies GEO Profiles Analyze DataSet
Cytotoxic activity of HTI-286 in prostate cancer
PubMed Similar studies Analyze with GEO2R
Effect of AZD1208 on gene expression in recurrent resistant Myc-CaP tumors grown in castrated mice.
PubMed Full text in PMC Similar studies Analyze with GEO2R
Expression data from docetaxel-resistant prostate cancer cell lines
Docetaxel resistant prostate cancer cell line
Strigolactone analogs induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cells
U2OS osteosarcoma cell line response to strigolactone analogs ST362 and MEB55: 24 hours
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
U2OS osteosarcoma cell line response to strigolactone analogs ST362 and MEB55: 6 hours
Effect of bone marrow microenvironment on the sensitivity of breast cancer cells to antiestrogens
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Effects of WCE herbal extract on hormone-refractory PC-3 tumors
PubMed Full text in PMC Similar studies SRA Run Selector
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [RNA-seq]
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [ChIP-seq]
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [CWR22 xenograft]
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome
PubMed Full text in PMC Similar studies
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [CWR22_EPIC]
NCOR2 controls androgen deprivation therapy failure in advanced prostate cancer through re-wiring of the onco-epigenome [CellLine_EPIC]
Regulation of anti-tumorigenic pathways by the combinatory treatment of calcitriol and TGF-β in PC-3 cells
Analyzing The Effects of ProL1 Upregulation On PC3 Global Gene Expression
Analyzing The Effects of ProL1 Upregulation On LNCaP Global Gene Expression
Comparing 2-dimensional vs. 3-dimensional human prostate cancer transcriptomes uncovers growth-specific gene signatures
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on